bioMérieux
Benjamin Pascal currently serves as the Global Head of the xPRO Program at bioMérieux, leading initiatives to develop innovative molecular assays that address emerging challenges in genomics and microbiology. Prior to this role, Benjamin held the position of Chief Business Officer at Invisible Sentinel, Inc., where advancements in Veriflow® technology were made. Benjamin's experience also includes serving on the Board of the Myrtle Siegfried, MD and Michael Vigilante, MD Scholarship and working as an Infection Control Specialist at B.Braun. Benjamin holds an MBA in Entrepreneurship from Lehigh University and a degree from The George Washington University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
bioMérieux
20 followers
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.